$QSEP
QS Energy, Inc.

2024 Q3 Form 10-Q Financial Statement

#000168316824005414 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $48.00K $48.00K
YoY Change 2.13% 2.13%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $48.00K $48.00K
YoY Change 2.13% 2.13%
Operating Profit -$279.0K -$249.0K
YoY Change 32.23% 21.46%
Interest Expense -$86.00K -$84.00K
YoY Change -4.44% 6.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$365.0K -$333.0K
YoY Change 21.67% 17.25%
Income Tax
% Of Pretax Income
Net Earnings -$365.0K -$333.0K
YoY Change 21.26% 17.25%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 405.9M shares 397.9M shares
Diluted Shares Outstanding 406.8M shares 398.5M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.0K $132.0K
YoY Change 12.86% 83.33%
Cash & Equivalents $237.0K $132.0K
Short-Term Investments
Other Short-Term Assets $12.00K $12.00K
YoY Change -60.0% 300.0%
Inventory
Prepaid Expenses $12.00K $12.00K
Receivables
Other Receivables
Total Short-Term Assets $249.0K $144.0K
YoY Change 4.18% 92.0%
LONG-TERM ASSETS
Property, Plant & Equipment $1.000K $1.000K
YoY Change -66.67% -75.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.000K $1.000K
YoY Change -66.67% -75.0%
TOTAL ASSETS
Total Short-Term Assets $249.0K $144.0K
Total Long-Term Assets $1.000K $1.000K
Total Assets $250.0K $145.0K
YoY Change 3.31% 83.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.374M $2.315M
YoY Change 10.99% 11.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.476M $2.340M
YoY Change 12.04% 16.01%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.802M $5.687M
YoY Change 9.82% 12.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.802M $5.687M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.802M $5.687M
YoY Change 9.82% 12.44%
SHAREHOLDERS EQUITY
Retained Earnings -$126.5M -$126.1M
YoY Change 1.16% 1.11%
Common Stock $410.6K $402.1K
YoY Change 5.56% 4.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.552M -$5.542M
YoY Change
Total Liabilities & Shareholders Equity $250.0K $145.0K
YoY Change 3.31% 83.54%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$365.0K -$333.0K
YoY Change 21.26% 17.25%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$270.0K -$149.0K
YoY Change 42.11% -5.7%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 375.0K 203.0K
YoY Change 13.64% 65.04%
NET CHANGE
Cash From Operating Activities -270.0K -149.0K
Cash From Investing Activities
Cash From Financing Activities 375.0K 203.0K
Net Change In Cash 105.0K 54.00K
YoY Change -25.0% -254.29%
FREE CASH FLOW
Cash From Operating Activities -$270.0K -$149.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-205000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-622000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
95000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-249000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-445000 usd
CY2024Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2023Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2024Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
84000 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
79000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
160000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
173000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
398506532 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
398506532 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
385223010 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
385223010 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395939821 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
395939821 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
381838227 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
381838227 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5382000 usd
CY2024Q2 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
50000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
105000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-333000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5542000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5244000 usd
qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
127000 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
190000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
18000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
9000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140000 usd
us-gaap Net Income Loss
NetIncomeLoss
-782000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5542000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4785000 usd
CY2023Q2 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
26000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
56000 usd
CY2023Q2 qsep Common Stock Issued On Exercise Of Warrants
CommonStockIssuedOnExerciseOfWarrants
3000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-284000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
170000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
103000 usd
qsep Common Stock Issued On Exercise Of Warrants
CommonStockIssuedOnExerciseOfWarrants
42000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
us-gaap Net Income Loss
NetIncomeLoss
-782000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
9000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
14000 usd
qsep Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
140000 usd
qsep Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
60000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
15000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
117000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
118000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-319000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-304000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
42000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
382000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
210000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
381000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
62000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-61000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
qsep Conversion Of Convertible Debentures To Common Stock
ConversionOfConvertibleDebenturesToCommonStock
127000 usd
qsep Conversion Of Convertible Debentures To Common Stock
ConversionOfConvertibleDebenturesToCommonStock
170000 usd
qsep Relative Fair Value Of Warrants Issued With Convertible Notes
RelativeFairValueOfWarrantsIssuedWithConvertibleNotes
190000 usd
qsep Relative Fair Value Of Warrants Issued With Convertible Notes
RelativeFairValueOfWarrantsIssuedWithConvertibleNotes
103000 usd
us-gaap Net Income Loss
NetIncomeLoss
-782000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-319000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5542000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
2200000 usd
CY2024Q2 us-gaap Cash
Cash
132000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zoiRcnwyycAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_86C_zm85c76NAMH7">Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87036638 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82422788 shares
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1476000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1332000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
900000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
794000 usd
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2376000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2265000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
74000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2302000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2101000 usd
us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
As of June 30, 2024, convertible notes payable and accrued interest are convertible into approximately 40,727,124 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share.
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
30000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
95000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001683168-24-005414-index-headers.html Edgar Link pending
0001683168-24-005414-index.html Edgar Link pending
0001683168-24-005414.txt Edgar Link pending
0001683168-24-005414-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsenergy_ex3101.htm Edgar Link pending
qsenergy_ex3102.htm Edgar Link pending
qsenergy_ex3200.htm Edgar Link pending
qsenergy_i10q-063024.htm Edgar Link pending
qsep-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
qsep-20240630_cal.xml Edgar Link unprocessable
qsep-20240630_def.xml Edgar Link unprocessable
qsep-20240630_lab.xml Edgar Link unprocessable
qsep-20240630_pre.xml Edgar Link unprocessable
qsenergy_i10q-063024_htm.xml Edgar Link completed
Show.js Edgar Link pending